Importantly, the addition of the 41BB-agonist to the IRE+CpG/pIC/PD-L1- Ab treatment to yield the IRE+Combo regimen completely eradicated s.c. 3LLOVA cancer in 75% of treated mice (Figures 2D, E). The gene discussed is CD274; the disease is cancer.